What is the correct DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) diagnosis for a patient with a history of Substance-Induced Mania (antidepressant-induced, recurrent) and Bipolar II Disorder, who has experienced multiple depressive episodes, including two with psychotic features?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DSM-5 Diagnosis for Antidepressant-Induced Mania in Bipolar II Disorder with Psychotic Depression

The correct DSM-5 diagnosis is Bipolar I Disorder, Current Episode Depressed (or Most Recent Episode Depressed), Severe with Psychotic Features. 1, 2

Diagnostic Reasoning

Why This Patient Has Bipolar I, Not Bipolar II

Antidepressant-induced manic episodes "upgrade" the diagnosis from Bipolar II to Bipolar I, despite the manic episodes being substance-induced. 1 According to the American Academy of Child and Adolescent Psychiatry, a manic episode precipitated by an antidepressant is characterized as substance-induced per DSM-IV-TR criteria, but critically, this represents either the unmasking of the underlying disorder or disinhibition secondary to the agent. 1

The key diagnostic principle is that recurrent antidepressant-induced mania in a patient with an established bipolar disorder indicates the presence of full manic potential, which by definition means the patient has Bipolar I Disorder, not Bipolar II. 1, 2 The substance merely triggered what the underlying illness was capable of producing.

Psychotic Features Specification

The presence of two psychotic depressions requires the "with psychotic features" specifier for the current or most recent depressive episode. 2, 3 This is a severity marker that must be documented in the diagnosis, as psychotic features significantly impact treatment planning and prognosis. 2

Why Substance-Induced Bipolar Disorder Is Not the Primary Diagnosis

The DSM-5 criteria for substance/medication-induced disorders require that the disorder "resembles" the full criteria for the relevant disorder and that the substance must be pharmacologically capable of producing the psychiatric symptoms. 4 However, when a patient has an established underlying bipolar disorder with multiple depressive episodes (including psychotic depressions), the antidepressant-induced manic episodes represent manifestations of the primary bipolar disorder, not a separate substance-induced condition. 1, 5

The American Psychiatric Association specifies that substance-induced symptoms should remit within days to weeks of abstinence, typically within 4 weeks. 6, 5 If manic symptoms recur with repeated antidepressant exposure in the context of an established bipolar disorder, this pattern indicates an independent (primary) bipolar disorder rather than a purely substance-induced condition. 4, 6

Critical Diagnostic Pitfalls to Avoid

Do not maintain a Bipolar II diagnosis once full manic episodes have occurred, even if substance-induced. 1, 2 The distinction between Bipolar I and Bipolar II is based on whether the patient has ever experienced a full manic episode (versus hypomania only). 2 Once mania has occurred—regardless of the trigger—the diagnosis must be upgraded to Bipolar I. 1

Do not diagnose this as a substance/medication-induced bipolar disorder as the primary diagnosis. 4 The recurrent pattern of multiple depressions (two with psychotic features) establishes an independent bipolar disorder that predates and exists beyond the antidepressant-induced manic episodes. 1, 2

Recognize that antidepressants in Bipolar II patients can unmask the full manic potential of the illness. 1, 7 This is particularly relevant because Bipolar II patients often receive antidepressants for their depressive episodes, and the resulting mania reveals the true nature of their illness as Bipolar I. 1, 2, 7

Treatment Implications

Antidepressants should be avoided or used with extreme caution in this patient. 1, 7 The recurrent antidepressant-induced mania demonstrates that this patient is highly vulnerable to mood destabilization with antidepressant use. 1, 7 If antidepressants are considered for future depressive episodes, they must be combined with robust mood stabilization, though avoidance may be the safest approach. 1, 7

Mood stabilizers (lithium, valproate) or second-generation antipsychotics should be the foundation of treatment. 1, 8 Given the history of psychotic features, antipsychotics may be particularly appropriate for both acute and maintenance treatment. 1, 8


Correct DSM-5 Diagnosis: Bipolar I Disorder, Current Episode Depressed (or Most Recent Episode Depressed), Severe with Psychotic Features

References

Guideline

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

Journal of the American Academy of Child and Adolescent Psychiatry, 2007

Research

Schizoaffective Disorder in the DSM-5.

Schizophrenia research, 2013

Guideline

Differential Diagnosis of Hallucinations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duration of Substance-Induced Psychosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?].

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2007

Related Questions

What is the best treatment approach for an adult male with a history of bipolar II disorder with psychotic features and multiple episodes of antidepressant-induced psychosis?
What is the best course of treatment for a patient with bipolar II disorder and a history of antidepressant-induced psychosis who is responding well to Emsam (selegiline) 12 mg/d?
What is the correct diagnosis and treatment approach for a patient with Bipolar II Disorder, a history of Substance-Induced Manic Psychosis (antidepressant-induced), and multiple depressive episodes, two of which included psychotic features?
What is the diagnosis for a 62-year-old female patient with poor sleep, fatigue, rapid mood changes, projection, rigid need for control, irritability, anhedonia, excessive uncontrollable worry, bursts of anger, and mania-like episodes, with normal electrocardiogram (ECG), normal thyroid profile, and no substance use?
What is the most likely diagnosis for a patient presenting with manic and depressive symptoms, including hyperactivity, increased energy, rapid speech, grandiose beliefs, feelings of worthlessness and guilt, and a history of slowed behavior?
What is the recommended workup and management for a patient presenting with symptoms suggestive of Ehlers-Danlos syndrome (EDS)?
What are the next steps in managing a patient with an enlarged liver, diffusely increased echo texture on ultrasound, a 4.5 cm cyst in the right lobe, mild splenomegaly, and slightly elevated Aspartate Aminotransferase (AST) of 39?
What are the potential complications and treatment options for a patient with a history of kidney stones and anorectal surgery, who underwent a kidney stone procedure with stent placement and subsequent removal, and is now experiencing worsening urinary sensations?
What is the half-life of pulmonary surfactant in patients with respiratory distress syndrome?
How to manage a patient with hypertension or angina and asthma or Chronic Obstructive Pulmonary Disease (COPD) who is taking diltiazem and salbutamol (albuterol)?
What is the optimal management strategy for a patient with heart failure with reduced ejection fraction (HFrEF) and impaired functional status?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.